Dr. Michael P Fischbein M.D., PHD
Cardiothoracic Surgeon
300 Pasteur Dr Stanford CA, 94305About
Dr. Michael Fischbein is a cardiothoracic surgeon practicing in Stanford, CA. Dr. Fischbein specializes in surgical procedues of vital organs in the chest such as the heart, lungs, esophagus and more. As a cardiothoracic surgeon, Dr. Fischbein typically treats conditions like heart disease and lung disease. This class of surgeon can also include cardiac surgeons, cardiovascular surgeons, congenital heart surgeons and general thoracic surgeons.
Education and Training
Boston University School of Medicine 1995
Board Certification
SurgeryAmerican Board of SurgeryABS
Thoracic SurgeryAmerican Board of Thoracic SurgeryABTS
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
- Stem cell transplantation: the lung barrier.
- Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
- Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease.
- Long-term durability of open thoracic and thoracoabdominal aneurysm repair.
- The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice.
- IL-17 contributes to the development of chronic rejection in a murine heart transplant model.
- Micro-CT for characterization of murine CV disease models.
- Prevention of transplant coronary artery disease by prenylation inhibitors.
- αB-crystallin improves murine cardiac function and attenuates apoptosis in human endothelial cells exposed to ischemia-reperfusion.
- Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.
- In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium.
- Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.
- miR-29b participates in early aneurysm development in Marfan syndrome.
- A novel cardioprotective agent in cardiac transplantation: metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection.
Clinical Trials
- Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 2)
- Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
Awards
- Boston University School of Medicine 1994 Alpha Omega Alpha
- 2003 Donald Morton Research Award, Department of Surgery - UCLA School of
- International Society for Heart and Lung Transplantation - Osaka, Jap 2000 Caves Scientific Award
- Boston University School of Medicine 1995 Cum Laude Graduate
Treatments
- Aortic Disease
- Heart Disease
- Aneurysm
- Congenital Heart Disease
- Aortic Aneurysm
- Coronary Artery Disease (cad)
Fellowships
- Stanford University Medical Center CA 2006
Publications
- CIRCULATION RESEARCHmiR-29b Participates in Early Aneurysm Development in Marfan Syndrome2012
- TransfusionOpen aortic valve replacement in a patient with Glanzmann's thrombasthenia2014
- jourl of experimental medicineA common rejection module2013
- JOURL OF THORACIC AND CARDIOVASCULAR SURGERYTirone David valve-sparing aortic root replacement2013
- JOURL OF THORACIC AND CARDIOVASCULAR SURGERYDavid valve-sparing aortic root replacement2013
- JOURL OF THORACIC AND CARDIOVASCULAR SURGERYBicuspid aortic valve configuration2012
- ANLS OF THORACIC SURGERYPotential Role of gamma delta T Cell-Derived IL-17 in Acute Cardiac Allograft Rejection2012
- NEW ENGLAND JOURL OF MEDICINETwo-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement2012
- JACC-CARDIOVASCULAR IMAGINGMolecular Imaging of Bone Marrow Mononuclear Cell Survival2012
- ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIn Vivo Functiol and Transcriptiol Profiling of Bone Marrow Stem Cells After Transplantation Into2012
- JOURL OF HEART AND LUNG TRANSPLANTATIONInterleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac2011
- Yale jourl of biology and medicineA novel cardioprotective agent in cardiac transplantation2011
- Itoh, S., Kimura, N., Axtell, R. C., Velotta, J. B., Gong, Y., Wang, XInterleukin-17 Accelerates Allograft Rejection by Suppressing Regulatory T Cell Expansion2011
- JOURL OF HEART AND LUNG TRANSPLANTATIONPrevention of transplant corory artery disease by prenylation inhibitors2011
- ANLS OF THORACIC SURGERYalpha B-Crystallin Improves Murine Cardiac Function2011
- ANLS OF THORACIC SURGERYPeninsula- Style Transverse Aortic Arch Replacement in Patients With Bicuspid Aortic Valve2010
- JOURL OF HEART AND LUNG TRANSPLANTATIONThe role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL2010
- JOURL OF CLINICAL IMMUNOLOGYIL-17 Contributes to the Development of Chronic Rejection in a Murine Heart Transplant Model2010
- SEMIRS IN VASCULAR SURGERYLong-Term Durability of Open Thoracic and Thoracoabdomil Aneurysm Repair2009
- CIRCULATIONComparison of different adult stem cell types for treatment of myocardial ischemia2008
- AMERICAN JOURL OF TRANSPLANTATIONEffect of inhaled tacrolimus on cellular2007
- TRANSPLANT IMMUNOLOGYTechniques for experimental heterotopic2007
- TRANSPLANTATION PROCEEDINGSStem cell transplantation: The lung barrier2007
- TRANSPLANTATION PROCEEDINGSIs the malononitrilamide FK778 better for the prevention of acute or chronic rejection?2007
Dr. Michael P Fischbein M.D., PHD's Practice location
Dr. Michael P Fischbein M.D., PHD's reviews
Write ReviewPatient Experience with Dr. Fischbein
Recommended Articles
- Congestive Heart Failure: What is Coronary Artery Bypass Surgery (CABG)?
Congestive Heart Failure is the leading cause of emergency hospitalization among people aged over sixty. It is a condition where the heart is inefficient in pumping the required amount of blood to the other parts of the body. This inefficiency can sometimes be so severe that it can impair the...
- How Does your Triglyceride Level Affect You?
Triglycerides are produced as a product of breakdown of fats. It is also produced from carbohydrates to be stored as energy. Triglycerides are generally stored in fat cells and released when needed.The healthy range or normal level of triglycerides in the body is less than 150 milligrams per...
- Are There Benign and Malignant Tumors of the Heart?
It is a well-known fact that in the body, in various tissues due to various reasons, neoplasms sometimes appear in the form of tumor growths. The heart is not an exception. The tumor growth can be benign and malignant. Therefore, there are two types of the heart tumors.Benign tumors These do not...
- Complications of Myocardial Infarction
Complications can be divided according to different factors:...
- Atypical Forms of Myocardial Infarction
Atypical myocardial infarction often occurs in older patients with a pronounced cardiosclerosis, circulatory failure, and often with people who have a history of heart attacks.The symptoms may confuse you, or make you think that they are not associated with the heart.Usually, atypical manifestations...
- Alternative Remedies to Treat Cardiovascular Diseases
Herbal Treatment of the heart has been used by mankind for centuries and has shown an excellent effect. Especially effective was the use of medicinal plants in the case of chronic diseases, such as atherosclerosis and hypertension, where treatment involves a particular duration and a comprehensive...
Nearby Providers
- Dr. Michael S. Shillingford M.D.300 Pasteur Dr Stanford CA 94305
- Richard Ha M.D.710 Lawrence Expy Santa Clara CA 95051
- Dr. Tomomi Oka MD1501 TROUSDALE DR BURLINGAME CA 94010
- Dr. Jack H Boyd MD300 PASTEUR DR STANFORD CA 94305
- Dr. Pei H Tsau MD87 ENCINA AVE PALO ALTO CA 94301
- Dr. David Craig Miller M.D.300 Pasteur Dr Stanford CA 94305